NCT00840320View on ClinicalTrials.gov

Repeat Dose Safety Study for Compound to Treat Anemia

PHASE1CompletedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

March 13, 2009

Primary Completion Date

September 2, 2009

Study Completion Date

September 2, 2009

Conditions

Kidney Disease

Interventions

DRUG

1278863

15mg, 25mg, 50mg, 150mg

DRUG

Placebo

matching placebo

Trial Locations (1)

3004

GSK Investigational Site, Melbourne

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT00840320 - Repeat Dose Safety Study for Compound to Treat Anemia | Biotech Hunter | Biotech Hunter